CY1106825T1 - Θεραπεια καρκινων με απλιδινη - Google Patents

Θεραπεια καρκινων με απλιδινη

Info

Publication number
CY1106825T1
CY1106825T1 CY20071101110T CY071101110T CY1106825T1 CY 1106825 T1 CY1106825 T1 CY 1106825T1 CY 20071101110 T CY20071101110 T CY 20071101110T CY 071101110 T CY071101110 T CY 071101110T CY 1106825 T1 CY1106825 T1 CY 1106825T1
Authority
CY
Cyprus
Prior art keywords
aplidine
treatment
cancer
tumors
complementing
Prior art date
Application number
CY20071101110T
Other languages
Greek (el)
English (en)
Inventor
Glynn Thomas Faircloth
Chris Twelves
Luis Paz-Ares
Original Assignee
Pharma Mar S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9927006.8A external-priority patent/GB9927006D0/en
Priority claimed from GB0005701A external-priority patent/GB0005701D0/en
Priority claimed from GB0007639A external-priority patent/GB0007639D0/en
Priority claimed from GB0015496A external-priority patent/GB0015496D0/en
Priority claimed from GB0025209A external-priority patent/GB0025209D0/en
Application filed by Pharma Mar S.A. filed Critical Pharma Mar S.A.
Publication of CY1106825T1 publication Critical patent/CY1106825T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CY20071101110T 1999-11-15 2007-08-30 Θεραπεια καρκινων με απλιδινη CY1106825T1 (el)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GBGB9927006.8A GB9927006D0 (en) 1999-11-15 1999-11-15 Aplidine treatment of cancers
GB0005701A GB0005701D0 (en) 2000-03-09 2000-03-09 Antitumor utility of aplidine
GB0007639A GB0007639D0 (en) 2000-03-29 2000-03-29 Antitumour and anti-angiogenic compound
GB0015496A GB0015496D0 (en) 2000-06-23 2000-06-23 Antitumour and anti-angiogenic compound
GB0025209A GB0025209D0 (en) 2000-10-13 2000-10-13 Treatment of cancers
PCT/GB2000/004349 WO2001035974A2 (en) 1999-11-15 2000-11-15 Aplidine treatment of cancers

Publications (1)

Publication Number Publication Date
CY1106825T1 true CY1106825T1 (el) 2012-05-23

Family

ID=27515929

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071101110T CY1106825T1 (el) 1999-11-15 2007-08-30 Θεραπεια καρκινων με απλιδινη

Country Status (27)

Country Link
US (1) US20090298752A1 (enExample)
EP (1) EP1229922B1 (enExample)
JP (1) JP2003514025A (enExample)
KR (1) KR100518986B1 (enExample)
CN (1) CN1423564A (enExample)
AT (1) ATE363910T1 (enExample)
AU (1) AU780417B2 (enExample)
BG (1) BG65381B1 (enExample)
BR (1) BR0015811A (enExample)
CA (1) CA2391502A1 (enExample)
CY (1) CY1106825T1 (enExample)
CZ (1) CZ302498B6 (enExample)
DE (1) DE60035120T2 (enExample)
DK (1) DK1229922T3 (enExample)
ES (1) ES2288486T3 (enExample)
HK (1) HK1045648B (enExample)
HU (1) HUP0203906A2 (enExample)
IL (1) IL149488A0 (enExample)
MX (1) MXPA02004862A (enExample)
NO (1) NO330719B1 (enExample)
NZ (1) NZ518847A (enExample)
PL (1) PL200922B1 (enExample)
PT (1) PT1229922E (enExample)
RU (1) RU2261104C2 (enExample)
SI (1) SI1229922T1 (enExample)
SK (1) SK287762B6 (enExample)
WO (1) WO2001035974A2 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030148933A1 (en) 1990-10-01 2003-08-07 Pharma Mar S.A. Derivatives of dehydrodidemnin B
GB9803448D0 (en) 1998-02-18 1998-04-15 Pharma Mar Sa Pharmaceutical formulation
UA76718C2 (uk) 2000-06-30 2006-09-15 Фарма Мар, С.А. Протипухлинні похідні аплідину
BR0114604A (pt) 2000-10-12 2003-10-14 Pharma Mar Sa Tratamento de c‰nceres
EP1435991B1 (en) * 2001-10-19 2008-10-15 Pharma Mar, S.A. Use of aplidine for the treatment of pancreatic cancer
PL368458A1 (en) * 2001-10-19 2005-03-21 Pharmamar S.A. Improved use of antitumoral compound in cancer therapy
KR20060002778A (ko) * 2003-03-12 2006-01-09 파르마 마르, 에스.에이. 개선된 항종양 치료
JP4584245B2 (ja) 2003-03-12 2010-11-17 ダナ−ファーバー キャンサー インスティテュート，インコーポレイテッド 多発性骨髄腫治療用のアプリジン
HUE028055T2 (en) * 2006-02-28 2016-11-28 Pharma Mar Sa Improved treatment of myeloma multiplex
EP2117539B1 (en) * 2006-11-03 2010-09-01 Nerviano Medical Sciences S.r.l. A method of administering an antitumor compound
RU2360712C1 (ru) * 2007-10-02 2009-07-10 Федеральное государственное учреждение "Ростовский научно-исследовательский онкологический институт Росмедтехнологий" Способ лечения местно-распространенного неоперабельного рака прямой кишки
AU2008313627A1 (en) * 2007-10-19 2009-04-23 Pharma Mar, S.A. Improved antitumoral treatments
CN101965191A (zh) * 2008-03-07 2011-02-02 法马马有限公司 改善的抗癌治疗
CN103463020B (zh) * 2013-09-23 2015-11-25 李淑兰 Lycojaponicumin A在制备治疗肾癌药物中的应用
LT3615544T (lt) 2017-04-27 2023-05-10 Pharma Mar S.A. Priešnavikiniai junginiai

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4342744A (en) * 1979-07-19 1982-08-03 Lever Brothers Company Hair treatment products
DE3161556D1 (en) * 1980-09-12 1984-01-05 Univ Illinois Novel antibiotics, derivatives thereof, processes for their extraction, and compositions containing them
US4950649A (en) * 1980-09-12 1990-08-21 University Of Illinois Didemnins and nordidemnins
US4493796A (en) * 1980-09-12 1985-01-15 Board Of Trustees, Univ. Of Ill. Didemnins A, B, C, and derivatives thereof, as antiviral agents
IT1153974B (it) * 1982-09-23 1987-01-21 Erba Farmitalia Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento
ATE74761T1 (de) * 1985-09-20 1992-05-15 Cernitin Sa Verwendung von pflanzenpollenextrakten zur herstellung von das wachstum von tumorzellen hemmenden pharmazeutischen praeparaten und verfahren zu ihrer herstellung.
US20030148933A1 (en) * 1990-10-01 2003-08-07 Pharma Mar S.A. Derivatives of dehydrodidemnin B
GB8922026D0 (en) * 1989-09-29 1989-11-15 Pharma Mar Sa Novel anti-viral and cytotoxic agent
US5580871A (en) * 1992-11-20 1996-12-03 The Dupont Merck Pharmaceutical Company 4-Heteroaryl- 1,4-dihydropyridine compounds with calcium agonist and alpha1 -antagonist activity
FR2698543B1 (fr) * 1992-12-02 1994-12-30 Rhone Poulenc Rorer Sa Nouvelles compositions à base de taxoides.
US5462726A (en) * 1993-12-17 1995-10-31 Bristol-Myers Squibb Company Method of inhibiting side effects of solvents containing ricinoleic acid or castor oil or derivatives thereof employing a thromboxane A2 receptor antagonist and pharmaceutical compositions containing such solvents
DE69431071T2 (de) * 1993-12-29 2003-03-20 Matrix Pharma Zusammensetzung für lokale freigabe von zytostatika
US5861439A (en) * 1994-11-14 1999-01-19 Alza Corporation Method for enhanced electrotransport agent delivery
US6365597B1 (en) * 1996-02-14 2002-04-02 Aventis Pharmaceuticals Inc. 4-aza steroids
EP0914116B1 (en) * 1996-05-22 2000-10-11 Protarga Inc. Compositions comprising conjugates of cis-docosahexaenoic acid and taxotere
US5795909A (en) * 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
US6156724A (en) * 1996-06-07 2000-12-05 Rinehart; Kenneth L. Uses of didemnins as immunomodulating agents
US6034058A (en) * 1997-04-15 2000-03-07 Rinehart; Kenneth L. Semi-synthetic alanyl dilemnin analogs
WO1998050048A1 (en) * 1997-05-07 1998-11-12 Pharma Mar, S.A. Aplidine as an l-type calcium channel enhancer
US6245759B1 (en) * 1999-03-11 2001-06-12 Merck & Co., Inc. Tyrosine kinase inhibitors
US20010021380A1 (en) * 1999-04-19 2001-09-13 Pluenneke John D. Soluble tumor necrosis factor receptor treatment of medical disorders
US6890904B1 (en) * 1999-05-25 2005-05-10 Point Therapeutics, Inc. Anti-tumor agents
ES2272462T3 (es) * 2000-04-07 2007-05-01 The Trustees Of The University Of Pennsylvania Analogos de tamadarina y didemnina y procedimiento de fabricacion y uso.
US6509315B1 (en) * 2000-04-07 2003-01-21 The Trustees Of The University Of Pennsylvania Didemnin analogs and fragments and methods of making and using them
UA76718C2 (uk) * 2000-06-30 2006-09-15 Фарма Мар, С.А. Протипухлинні похідні аплідину
AU1305302A (en) * 2000-10-05 2002-04-15 Immunex Corp Nectin polypeptides, polynucleotides, methods of making and use thereof
BR0114604A (pt) * 2000-10-12 2003-10-14 Pharma Mar Sa Tratamento de c‰nceres
WO2002032374A2 (en) * 2000-10-18 2002-04-25 Immunex Corporation Methods for treating il-18 mediated disorders
US6610399B1 (en) * 2000-11-17 2003-08-26 Structural Technologies, Llc Multi-layer, thermal protection and corrosion protection coating system for metallic tendons, especially for external post-tensioning systems
EP1435991B1 (en) * 2001-10-19 2008-10-15 Pharma Mar, S.A. Use of aplidine for the treatment of pancreatic cancer
KR20060002778A (ko) * 2003-03-12 2006-01-09 파르마 마르, 에스.에이. 개선된 항종양 치료
JP4584245B2 (ja) * 2003-03-12 2010-11-17 ダナ−ファーバー キャンサー インスティテュート，インコーポレイテッド 多発性骨髄腫治療用のアプリジン
AU2004224418A1 (en) * 2003-03-21 2004-10-07 Madeleine M. Joullie Tamandarin analogs and fragments thereof and methods of making and using
US20060019256A1 (en) * 2003-06-09 2006-01-26 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
HUE028055T2 (en) * 2006-02-28 2016-11-28 Pharma Mar Sa Improved treatment of myeloma multiplex
AU2008313627A1 (en) * 2007-10-19 2009-04-23 Pharma Mar, S.A. Improved antitumoral treatments

Also Published As

Publication number Publication date
EP1229922A2 (en) 2002-08-14
NO20022293L (no) 2002-07-05
SI1229922T1 (sl) 2008-04-30
CN1423564A (zh) 2003-06-11
AU780417B2 (en) 2005-03-17
HUP0203906A2 (en) 2003-03-28
NO20022293D0 (no) 2002-05-14
MXPA02004862A (es) 2003-01-28
ES2288486T3 (es) 2008-01-16
HK1045648A1 (en) 2002-12-06
KR20020064313A (ko) 2002-08-07
AU1402301A (en) 2001-05-30
WO2001035974A2 (en) 2001-05-25
JP2003514025A (ja) 2003-04-15
EP1229922B1 (en) 2007-06-06
BG106714A (en) 2003-02-28
DK1229922T3 (da) 2007-10-08
SK6592002A3 (en) 2003-08-05
SK287762B6 (sk) 2011-09-05
WO2001035974A3 (en) 2001-11-01
PL200922B1 (pl) 2009-02-27
DE60035120T2 (de) 2008-01-31
NZ518847A (en) 2004-02-27
BR0015811A (pt) 2002-08-06
PT1229922E (pt) 2007-09-12
BG65381B1 (bg) 2008-05-30
IL149488A0 (en) 2002-11-10
CZ302498B6 (cs) 2011-06-15
RU2002115864A (ru) 2004-01-20
CA2391502A1 (en) 2001-05-25
ATE363910T1 (de) 2007-06-15
KR100518986B1 (ko) 2005-10-06
RU2261104C2 (ru) 2005-09-27
CZ20021697A3 (cs) 2003-02-12
US20090298752A1 (en) 2009-12-03
NO330719B1 (no) 2011-06-20
PL355335A1 (en) 2004-04-19
HK1045648B (en) 2007-09-21
DE60035120D1 (de) 2007-07-19

Similar Documents

Publication Publication Date Title
CY1111379T1 (el) Συνθεσεις και μεθοδοι για τη θεραπευτικη αντιμετωπιση πρωτογενων και μεταστατικων-νεοπλασματικων ασθενειων με τη χρηση τριοξειδιου του αρσενικου
DE69919695D1 (de) Texaphyrin-konjugate und ihre anwendiung
CY2013020I2 (el) Η χρηση μιας ενωσης ινγκενανης για την κατασκευη ενος φαρμακου για την θεραπεια του καρκινου
DK1229922T3 (da) Aplidin-behandling af cancere
IS6375A (is) Lyfjagjöf til öftrunar á blöðruhálskrabbameini
CY1116124T1 (el) Χρησεις αντισωματων για αμινοφωσφολιπιδια για τη θεραπευτικη αγωγη καρκινου
CY1105585T1 (el) Χρηση των πολυπεπτιδιων casb616 και πολυνουκλεοτιδιων για τη θεραπεια του καρκινου
PL354540A1 (en) Drugs for the treatment of malignant tumours
BR9710646A (pt) Pródrogas de paclitaxel solúveis em água.
MXPA01010393A (es) Tratamiento de neoplasmas con virus.
TR199800270T1 (xx) Kanser hastal�klar�n�n ilerlemesini �nlemede flukonazol kullan�m�.
ATE243692T1 (de) Arylaminderivate und ihre verwendung als antitelomerasemittel
AR035450A1 (es) Combinaciones antineoplasicas, el uso de dichas combinaciones para la preparacion de un medicamento, un producto que comprende dicha combinacion
CA2305790A1 (en) Styryl sulfone anticancer agents
TR200001687T2 (tr) Neopleasyo için N-benzil-3-indenilasetamid türevleri.
IL97055A0 (en) Pharmaceutical compositions for sensitizing tumor cells comprising quinazolinedione derivatives
BG108932A (en) Pharmaceutical composition comprising arsenite for the treatment of malignancy
YU29803A (sh) Kombinacija kamptotekina i derivata stilbena za lečenje raka
NO20014228L (no) Radioaktiv cisplatin i behandling av cancer
WO2004098651A3 (en) Bone localising radiopharmaceutical and tubulin-interacting compound combinatorial radiotherapy
TH1901008214A (th) เกลือชนิดใหม่ของ N-(2,6-ไดเอทธิลฟีนิล)-8-({4-[4-(ไดเมทธิลอะมิโน)พิเพอริดิน-1-อิล]-2-เมทธอกซีฟีนิล}อะมิโน)-1-เมทธิล-4,5-ไดไฮโดร-1H-ไพราโซโล[4,3-h]ควินาโซลีน-3-คาร์บอกซาไมด์ การจัดเตรียมของพวกมัน, และสูตรผสมซึ่งมีมันอยู่
UA30391A (uk) Спосіб лікування колоректального раку
CY1114560T1 (el) Χρηση πολυπεπτιδιων απροτινινης ως φορεις σε φαρμακευτικα συζευγματα
IT1309179B1 (it) Perfezionamenti ad una sonda-catetere per il trattamento di tumorimediante ipertermia interstiziale indotta da radiofrequenza.
RU2003130928A (ru) Способ комбинированного лечения местно-распространенных злокачественных опухолей трахеи и/или бронхов